Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
NextGen Therapeutics
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network.
NextGen Therapeutics
Tackling Tumours from Within: Tumour Reprogramming Offers Hope in Cancer Immunotherapy
A novel gene therapy developed by Asgard Therapeutics and Lund University reprograms tumour cells into cancer-fighting immune cells.
Microbiome
New Research into Newborn Gut Microbiome Identifies Three “Pioneer Bacteria” for Babies’ Microbiota Development
The researchers analysed high-resolution genomic information from over 1,200 babies and identified three pioneer bacteria that drive the development of the gut microbiota.
Drug Discovery & Development
Insilico Medicine and Inimmune Pen Collaboration for AI-Powered Immunotherapy Discovery
The two biotechs are working together to overcome specific hurdles in the immunotherapy drug discovery process.
Stem Cell Therapy
Kyoto University Hospital Explores the Potential of Treating Type 1 Diabetes Using Induced Pluripotent Stem Cells
Kyoto University Hospital aims to develop a treatment for severe Type 1 diabetes using induced pluripotent stem cells (iPSCs) reprogrammed to function as pancreatic islet cells.
Regulatory
Regeneron’s Bispecific Gets EU Approval After FDA Rejection
The approval means that the bispecific antibody odronextamab can be used to treat adult patients with relapsed or refractory follicular lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL) in the EU.
Antibody & Protein Engineering
Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI
The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.
Antibody-based Therapies
MSD to Acquire Bispecific Antibody From Curon in Bid to Diversify Portfolio
The novel investigational clinical stage bispecific antibody targets CD3xCD19 to engage T cells with malignant B cells.
Peptide Chemistry
RSC 'Emerging Technologies' Award Goes to Solid Phase Peptide Synthesis Group
The novel peptide synthesis protocol allows the synthesis of multiple peptide fragments on a single bead.
Gene Therapy Development
Jaguar Gene's JAG201 Therapy Trial for SHANK3 Haploinsufficiency Receives FDA Approval
JAG201 gene replacement therapy available to both child and adult patients is now in Phase I clinical trial.
Immunotherapy (Non-Oncology)
CAR T Beyond Cancer: Applying the Cell Therapy for Lupus and Other Autoimmune Diseases
Can CAR T, which has had successes in immuno-oncology, be applied to reset the immune system of autoimmune disease patients?
Cell Therapy Development
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK